TNX Investor Portal
The TNX Investor Portal gives you exclusive access to active funding rounds from founders we’re working with, connecting you to high-growth ventures ready to scale. All funding rounds are currently live in 2026.
For access to decks, data rooms, and introductions, email info@tnxconsulting.co.uk or use the contact form at the bottom of this page
SpawnPoint
Spawnpoint is the leading end-to-end freeroam VR platform powering large-scale multiplayer experiences for location-based entertainment, education, and training. Unlike competitors, it manages not just games but venues, hardware, content, and player accounts, creating strong operator lock-in and recurring revenue.
The platform already supports 850+ venues, has major partnerships with Ubisoft, HTC Vive, and international distributors, and is expanding rapidly into defence, education, and high-throughput immersive venues.
The company is raising £800k, targeting £6m annual turnover and £3m profit by year four. This round is not SEIS, but offers later-stage angels exposure to a fast-scaling, revenue-backed platform targeting a £5bn+ global market.
For exclusive access to this opportunity and to view a pitch deck email info@tnxconsulting.co.uk
Pharmalocity
Pharmalocity is a specialist marketplace connecting life sciences companies with vetted clinical research experts, effectively an “Upwork for clinical trials” built by industry insiders. It addresses a critical bottleneck where delays in sourcing niche expertise can cost up to £1m per day in lost programme value.
The platform already has paying subscribers, active clients, strong unit economics (9:1 LTV:CAC), and achieved traction with zero marketing spend. The company is raising at a £400k pre-money valuation, with angels able to invest from £20k for meaningful equity stakes.
This round is SEIS-eligible, offering exposure to a capital-efficient, high-margin SaaS marketplace with clear exit paths via CROs, recruiters, or SaaS acquirers.
For exclusive access to this opportunity and to view a pitch deck email info@tnxconsulting.co.uk
Pots by SGTL
Pots is a vertical marketplace and operating system for the UK gardening industry, enabling customers to instantly book trusted local gardeners while giving tradespeople professional tools to manage scheduling, payments, and growth.
The platform addresses a fragmented, largely offline market with over 144k registered gardeners in the UK, capturing value through booking fees, subscriptions, and partner commissions. Pots already has a live product, growing downloads, completed bookings, and demonstrated marketing ROI, showing early product–market fit at a local level.
The company has previously raised £180k pre-seed and is now raising £500k–£1m to scale county by county and drive the business towards profitability and a targeted £10m+ valuation.
This is a consumer-services marketplace with clear network effects, real-world traction, and strong SEIS-style asymmetric upside at an early scale-up stage.
For exclusive access to this opportunity and to view a pitch deck email info@tnxconsulting.co.uk
The Off Switch
The Off Switch is a physically enabled device paired with an app that helps individuals and organisations combat digital burnout by making phone disengagement a conscious, physical action. Designed for remote workers, employers, and schools, it supports UK “Right to Disconnect” expectations while avoiding data collection and privacy risks.
The product is live on the App Store, has active users, strong testimonials, and minimal direct competition in the UK. The company is raising £200k, primarily to enhance the app and build B2B distribution channels. SEIS eligibility is pending, making this an attractive early-stage consumer and corporate wellbeing investment with strong social impact and scale potential.
For exclusive access to this opportunity and to view a pitch deck email info@tnxconsulting.co.uk
SEEING Scientific
Working with the Medical Technologies Innovation Facility (MTIF), SEEING Scientific is integrating it's novel technology (with patents both granted and pending) into the prototype and build of the next-generation Laparoscope for keyhole surgery. £50-£350k SEIS/EIS is sought ahead of the innovation license being granted to an existing and well known global medical partner.
For exclusive access to this opportunity and to view a pitch deck email info@tnxconsulting.co.uk
IDM Insight (Clincraft)
IDM Insight is tackling the £60bn global clinical trials inefficiency problem by using AI to cut protocol design timelines, reduce costs, and improve trial inclusivity. Its flagship platform, ClinCraft, enables pharma and CROs to generate regulatory-ready trial protocols up to 40% faster, addressing delays that cost up to $500k per day per programme.
The company is already backed by Innovate UK, Nvidia, AWS, and CRO partners, with 25+ beta users, live pilots, and a strong enterprise pipeline. IDM is raising £1.5m at a £5m valuation, with SEIS/EIS available, to scale product capability, regulatory readiness, and commercial growth.
This is an opportunity to invest early in a defensible AI platform operating at the heart of regulated healthcare innovation.
For exclusive access to this opportunity and to view a pitch deck email info@tnxconsulting.co.uk
Minfo
![Minfo[1] b.png](https://static.wixstatic.com/media/d240c1_7db969e59f714d9ba33512a4efd99479~mv2.png/v1/fill/w_318,h_318,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/Minfo%5B1%5D%20b.png)
MINFO has built a patented AudioQR technology that turns passive media (TV, radio, public spaces) into instantly interactive, measurable engagement channels.
Positioned as a “Shazam for everything,” the platform enables brands and broadcasters to capture real-time attribution and actions from audiences, solving a £3.8bn UK TV advertising measurement gap.
The product is live on iOS, Android, and web, has secured three US patents, Innovate UK funding, and is launching the world’s first interactive community radio station.
The company is raising £350k via SAFE, providing a 12-month runway to scale downloads, partnerships, and broadcaster rollouts. SEIS eligibility is expected to apply, making this a compelling early-stage media-tech opportunity with strong IP protection.
For exclusive access to this opportunity and to view a pitch deck email info@tnxconsulting.co.uk
Confidential (Pre-Seed)
A significant £5m London based real estate opportunity, comprising a business in a unique sector. This is a medium risk £1m minimum ticket size opportunity.
For exclusive access to this opportunity and to view a pitch deck email info@tnxconsulting.co.uk
